FARMACOCINÉTICA Y FARMACODINAMIA esto es TODO LO QUE DEBES SABER | Farmacotips — Transcript
Full transcript
- 0:00Pharmacokinetics and pharmacodynamics
- 0:01are the basic pillars for you to
- 0:03understand every topic in pharmacology.
- 0:05Let me introduce myself, I am Javier
- 0:06Flores, a medical professor of
- 0:08pharmacology, and today I will explain
- 0:09the topic of pharmacodynamics and
- 0:11pharmacokinetics, all the points that
- 0:12were not explained in class and that
- 0:14are very important for you to be a pro
- 0:16in pharma. So let's get started. But
- 0:18before we start, don't forget to leave
- 0:19your like and your comment so I keep
- 0:20making this type of content, and
- 0:22subscribe. Now, let's go. First, a few
- 0:28topics we need to remember.
- 0:29Pharmacokinetics, absorption, and their
- 0:32characteristics. We will understand the
- 0:35first-pass phenomenon and the different
- 0:38facets within pharmacokinetics, which
- 0:41are distribution, metabolism, and
- 0:43excretion. What is pharmacokinetics?
- 0:49Well, broadly speaking, we can define
- 0:51it as the effect of the body on the
- 0:53drug, or better known as the
- 0:55dose-concentration effect. But we must
- 1:01first remember the pharmacokinetic
- 1:03processes to have a better context of
- 1:05how this property works within
- 1:07pharmacology. We will use an acronym
- 1:11known as LAATME, which will determine
- 1:14the following. The L is drug liberation
- 1:17, remembering that it is the release of
- 1:20the pharmaceutical form at the site of
- 1:23absorption. Now, the next process is
- 1:27clearly absorption, which is the
- 1:30movement of the drug into the
- 1:32bloodstream. Let's take an example. If
- 1:36our drug is a pill or a capsule, this
- 1:39medication's active ingredient is
- 1:42covered by a capsule. So, once our
- 1:45intestine releases the capsule and the
- 1:48active ingredient is absorbed in the
- 1:50intestine into the bloodstream, the
- 1:53next process is known as distribution.
- 1:57Distribution is the diffusion once it
- 1:59reaches the bloodstream or the
- 2:01transport of the drug to tissues or
- 2:03cells. This is very important, as the
- 2:08drug can stay in a tissue for a very
- 2:10long time and be released little by
- 2:13little, or otherwise reach cells that
- 2:15may be the point of action or places
- 2:17where it can be deposited. Metabolism
- 2:23is the chemical conversion of
- 2:25endogenous substances into metabolites.
- 2:28These metabolites can be both inactive
- 2:30and active metabolites. And the last
- 2:34point is elimination, which is the
- 2:36removal of the drug from the body
- 2:38through the renal, biliary, or
- 2:40pulmonary process, and we will evaluate
- 2:42that there are several; they do not
- 2:44necessarily have to be these three, but
- 2:46there are other methods of elimination
- 2:49that can be nails, tears, saliva,
- 2:51etcetera. If we put pharmacokinetics in
- 2:54a chart, we will notice that this is
- 2:56systemic circulation, this whole little
- 2:58box here, and the drug will clearly be
- 3:00free because it has already been
- 3:02absorbed, right? So the drug has a few
- 3:05options within the first two: that the
- 3:07drug binds to a protein, a molecule, or
- 3:09a tissue and remains deposited there,
- 3:12or alternatively, that it converts into
- 3:14metabolites even after its absorption.
- 3:18Now, depending on the different
- 3:20mechanisms that can occur, the first
- 3:22one is elimination. The drug is
- 3:25eliminated, right? But it is important
- 3:28to note that this is a two-way street,
- 3:30as within elimination there is a
- 3:32process known as reabsorption, which
- 3:34usually involves drugs that are
- 3:36uncharged and are quite important for
- 3:38the drug's action and can be reabsorbed
- 3:40. On the other hand, we also have that
- 3:43the drug can bind to receptors, and
- 3:45once it binds to receptors, the
- 3:47drug-receptor complex is formed, which
- 3:48we will see in the pharmacodynamics
- 3:50chapter, or it can also go to a tissue
- 3:52reservoir, which as I mentioned, is a
- 3:54storage action. But what happens with
- 3:58another group of drugs that are neither
- 4:00bound nor metabolites? These go to the
- 4:03liver and are metabolized, producing
- 4:05inactive metabolites which subsequently
- 4:07, correct?,will be eliminated via the
- 4:10renal or biliary route. Speaking
- 4:15specifically about absorption and its
- 4:17characteristics, we have to note what
- 4:20is important for a drug to be correctly
- 4:22absorbed. Liposolubility; the more
- 4:25liposoluble it is, the greater the
- 4:27absorption. Cell size; the smaller it
- 4:29is, the more rapidly it is absorbed,
- 4:31yes, but perhaps also much more rapidly
- 4:34eliminated. The absorption surface.
- 4:37Absolutely correct. Hypothetically,
- 4:39let's say our intestinal zone is
- 4:40affected; there is a smaller area where
- 4:42the drug can be absorbed, and therefore
- 4:43a smaller amount will reach the
- 4:45bloodstream. Ionization of the active
- 4:47ingredient. This is very important
- 4:50because drugs that are ionized or
- 4:52maintain a charge are much more quickly
- 4:54and easily eliminated, since they
- 4:56cannot be reabsorbed. On the other hand
- 5:01, what are the transport mechanisms or
- 5:02what ensures that this drug reaches the
- 5:04bloodstream? Well, these are the basics
- 5:07we learned in the biology section of
- 5:08our medical training or even in high
- 5:10school. We have the active pathways
- 5:13that use energy, the passive ones that
- 5:15do not use energy, simple diffusion, or
- 5:18facilitated diffusion which depends on
- 5:21transporters. On the other hand,
- 5:23filtration, which we can see much
- 5:25better in the following section. The
- 5:30next process to learn about is the
- 5:32first-pass effect. But what is the
- 5:35first-pass effect? Basically, the
- 5:38transformation of any drug into an
- 5:41active or inactive substance. And that
- 5:44point is very important, guys. Why?
- 5:47Since all drugs containing an active
- 5:50substance, as we can see here, are
- 5:53transformed in the liver very easily
- 5:56and simply into inactive metabolites;
- 5:59while there are others that are
- 6:02inactive, which, once they pass through
- 6:05the liver, take on a positive aspect or
- 6:08become activated, as they are known as
- 6:12prodrugs, which need to reach the liver
- 6:16to subsequently activate correctly and
- 6:19have an effect on the body. In the next
- 6:24process, known as distribution, we have
- 6:28three types of distribution, which are
- 6:31cellular storage, fat storage, or
- 6:34deposits at the site of absorption, the
- 6:38first being organs, which can be the
- 6:41liver as number one, spleen, heart, and
- 6:45blood circulation. Correct? There are
- 6:48certain types of drugs that remain
- 6:50within the bloodstream permanently,
- 6:53either because they are charged or are
- 6:55too large in size and cannot be
- 6:57eliminated. Fat deposits, on the other
- 7:00hand, have to do with redistribution.
- 7:03What does that mean? That it is the
- 7:05elimination of inactive drugs, as these
- 7:07attach themselves to fat deposits and
- 7:10are eliminated much faster.
- 7:11Unfortunately, there are no drugs that
- 7:13make you lose weight faster because
- 7:15they bind to fats. No, no, no. I want
- 7:17to clarify that, no. Deposits at the
- 7:20site of absorption, on the other hand,
- 7:23means those with low solubility, that
- 7:26is, they are absorbed as they
- 7:28solubilize. That is to say, a molecule
- 7:31attaches itself that must solubilize,
- 7:33and when this molecule solubilizes, the
- 7:35drug is released and therefore can have
- 7:37its effect on the body. When we talk
- 7:41about the biotransformation of a drug,
- 7:43it basically depends on the enzymes
- 7:45located in the reticulum of the liver.
- 7:47This explains why most metabolization
- 7:50or biotransformation occurs there,
- 7:52since these are scarce in other
- 7:55structures, like the kidney, lung, or
- 7:57gastrointestinal epithelium. Therefore,
- 8:01and I emphasize, it is due to its high
- 8:03rate or number of enzymes located in
- 8:06the liver that the greatest amount of
- 8:09metabolization occurs there. When we
- 8:14talk about metabolization or phase one,
- 8:17we talk about three subprocesses:
- 8:19oxidation, reduction, and hydrolysis.
- 8:23Now, at this point, we refer to the
- 8:25fact that oxidation is basically the
- 8:28addition of an oxygen group to the
- 8:30molecule with the chemical form of the
- 8:32drug so that it can disappear.
- 8:36Reduction, on the other hand, has to do
- 8:39with the removal of oxygen or the
- 8:41addition of a hydrogen ion group, and
- 8:43thus the chemical form of the drug is
- 8:46reduced. Hydrolysis, conversely, is
- 8:50where water—literally water—is
- 8:52responsible for breaking down the drug
- 8:54into water-associated substances. In
- 8:58phase two, or better known as
- 9:00conjugation, we talk about the drug
- 9:03going through five different
- 9:05sub-processes known as: glucuronidation
- 9:08, ethereal sulfates, acetylation, which
- 9:11is the most frequent of these processes
- 9:13to which most drugs are subjected,
- 9:16glycine conjugation, and the second
- 9:18most frequent, methylation. This will
- 9:22depend on which drug we are talking
- 9:23about, and in future classes, when we
- 9:25discuss a specific group of drugs, we
- 9:26will say, "Okay, this one is conjugated
- 9:28through such-and-such sub-process."
- 9:31What are the most well-known routes of
- 9:33elimination that we need to remember?
- 9:35The renal route, the pulmonary route,
- 9:38the digestive route, and—correct,
- 9:40guys? Other routes. As I mentioned, to
- 9:43make it more didactic so you remember
- 9:46it, the most frequent route of
- 9:48elimination will always be the renal
- 9:50route. Almost 90%of the drugs we use
- 9:56are eliminated via the renal route. The
- 10:00next 5%is split between the digestive
- 10:02route and other routes, and the
- 10:04remaining 5%will be via the pulmonary
- 10:06route. Within excretion, to have a
- 10:12clearer context, the renal route does
- 10:14it through renal filtration, tubular
- 10:17secretion, and tubular reabsorption.
- 10:20That is why if we have a drug that is
- 10:22eliminated via this route and it is
- 10:23given to a patient with renal
- 10:24insufficiency—which is very important
- 10:26to know—we will notice that there
- 10:28will be an accumulation of the drug in
- 10:29the organism, and that is correct. It
- 10:31can lead to having quite frequent and
- 10:33unexpected types of adverse reactions
- 10:36just because we did not take a proper
- 10:38medical history. The pulmonary route
- 10:40does it through active transport. These
- 10:42are mostly drugs that are used directly
- 10:44through the pulmonary route. And the
- 10:46digestive route involves saliva,
- 10:48enterohepatic circulation, and the
- 10:50rectal route. Now, what are the
- 10:55specific routes? Urine, the lungs that
- 10:59we already discussed, and the other
- 11:01routes I mentioned at the beginning of
- 11:04the video were saliva, sweat, and also
- 11:06through hair, tears, and others. The
- 11:09interesting thing is that the
- 11:10proportion here is so low that it is
- 11:12almost imperceptible and does not
- 11:14really have a very noticeable effect on
- 11:16the human being. So, how do we
- 11:18summarize pharmacokinetics? So, a chart
- 11:19that you can remember from here on out.
- 11:24First, drug liberation, which is
- 11:26basically the administration of the
- 11:28drug and the release of its active
- 11:30ingredient at the absorption site. The
- 11:34absorption site, on the other hand,
- 11:36when using the oral route, involves
- 11:38enteric transport and enteric
- 11:39metabolism for it to be absorbed. So,
- 11:42once the drug is absorbed, we move to
- 11:44the third point, which is distribution.
- 11:47Now, this can be intravascular,
- 11:49extravascular, or fixed through protein
- 11:51binding, because protein binding is the
- 11:53important factor for the drug's
- 11:55half-life. As I mentioned, this process
- 11:58applies if we use the oral route. But
- 12:01if the administration is intravenous,
- 12:03it is directly systemic, so clearly it
- 12:05does not need to be released or
- 12:07absorbed because it has already
- 12:08achieved the goal of reaching systemic
- 12:10circulation. Metabolism. So, as we have
- 12:14discussed, it goes through phase one
- 12:16and phase two, and subsequently, what
- 12:18happens? The elimination of the drug
- 12:20via one of the three most frequent
- 12:22routes, as well as the others we have
- 12:24discussed today. Now let's move on to
- 12:28the second part of today's class,
- 12:29pharmacodynamics. The topics for
- 12:34today's class are as follows: general
- 12:37pharmacodynamics, targets of action,
- 12:39receptors and drug-receptor
- 12:41interactions, dose-response curve—a
- 12:44point frequently asked about by all of
- 12:47you on my social media—and
- 12:49pharmacological tolerance, obviously
- 12:52differentiating it from resistance and
- 12:55tachyphylaxis. Before we continue,
- 12:58remember to subscribe and follow us on
- 12:59our social media so you can learn much
- 13:01more about pharmacology. Okay, before
- 13:04we get to the main part, we have to
- 13:06know the generalities. As we talked
- 13:09about pharmacokinetics, and I'll leave
- 13:11the video up here for you to watch if
- 13:13you didn't learn that class, we will
- 13:15speak about pharmacodynamics
- 13:16specifically as the effect of the drug
- 13:18on the organism, that is, the different
- 13:20actions that the drug performs in the
- 13:22body to produce a change in the
- 13:24organism. Whether this is beneficial or
- 13:27harmful. So, we define as a specific
- 13:30action the interaction with
- 13:32pharmacological targets.
- 13:35Pharmacological targets are the
- 13:37receptors or zones of action,
- 13:39non-specific actions that, due to the
- 13:42chemical properties of the drug or
- 13:44those it produces within the human
- 13:47being, are objectified and can be seen
- 13:49in it, that is, they are not the
- 13:52targets. Specificity is the selectivity
- 13:57for a determined receptor. And this is
- 14:01important, guys, since we have to
- 14:03remember that this is what will make it
- 14:05clear to us that a drug has a specific
- 14:08function. If drug A acts on receptor B
- 14:10and B produces an increase in blood
- 14:12pressure, period, that is what it does.
- 14:15But if drug A acts on receptors A and B
- 14:17, and the second one lowers blood
- 14:19pressure while the other one raises it,
- 14:21basically there will be no effect. That
- 14:24is what makes it quite good to have
- 14:26drugs that have specificity. And that
- 14:29is very simple to remember, because
- 14:32among the properties our drug has for
- 14:34this to occur are the following:
- 14:36chelation, molarity, and pH changes;
- 14:39since if one of them is altered in
- 14:41relation to the receptor, there will be
- 14:43no effect on the pharmacological target
- 14:46, and since there is no effect on the
- 14:48target, there will be no effect on the
- 14:51human being. When we talk about a
- 14:54pharmacological target, we are talking
- 14:55about three things specifically.
- 14:57Enzymes, transporters, and receptors.
- 15:01Enzymes likewise have an irreversible
- 15:03or reversible function, obviously
- 15:05remembering that irreversible means it
- 15:07attaches to the drug and is eliminated.
- 15:10Reversible means it attaches to the
- 15:12drug and then separates, and it can
- 15:13continue functioning. And of course,
- 15:15false substrates. What does this mean?
- 15:18That the drug has a conformational
- 15:20shape which will couple to the enzyme
- 15:21and eliminate it. Remember that
- 15:24sometimes in certain therapeutic
- 15:26actions there is an excess of enzymes
- 15:28and we must then decrease them with
- 15:30false substrates. Among transporters,
- 15:33the number one is the number one
- 15:35protein, if you will, in the body,
- 15:37which is albumin. And among receptors,
- 15:40we talk mostly about ion channels,
- 15:42because when we talk about ion channels
- 15:44, we have to remember that they are
- 15:46going to be in charge of what? Of
- 15:48modifying their function. And when we
- 15:51modify the function, we are talking
- 15:52about the opening or closing of the
- 15:53channel. And there are also other types
- 15:57of receptors which are G
- 15:58protein-coupled or second messenger,
- 16:01which are in charge of synthesizing a
- 16:03chemical second messenger, which can be
- 16:06calcium, cyclic AMP, among others,
- 16:08which will carry that information
- 16:10inside the cell and cause a
- 16:12conformational change. The most
- 16:16important thing about this is to
- 16:18remember where our receptors are
- 16:20located, which can be inside the
- 16:22membrane, outside the membrane, in the
- 16:24cytoplasm, or even in the nucleus.
- 16:29Among the receptor types, we talk about
- 16:31those that can be direct, like ion
- 16:33channels, or indirect, which are those
- 16:36of G protein or second messenger. On
- 16:41the other hand, when we talk about
- 16:43drug-receptor interactions, we are
- 16:45going to be a bit more precise
- 16:46regarding the type of bond present, the
- 16:48binding rate, and efficacy. The types
- 16:52can be irreversible, like covalent
- 16:54bonds, and reversible, like van der
- 16:56Waals forces, which are the weakest.
- 17:00The binding rate is the drug's ability
- 17:02to fix itself to a receptor. The higher
- 17:05this is, the more irreversible it will
- 17:08be. And efficacy, on the other hand, is
- 17:11the drug's capacity to produce a
- 17:13biological effect. Regarding the
- 17:17binding rate, we must remember the
- 17:20drug's function with the receptor to
- 17:22form the drug-receptor complex as such,
- 17:25while efficacy would be the
- 17:27drug-receptor complex and the
- 17:29possibility or capacity to produce the
- 17:31effect. According to the mechanism of
- 17:37action, we have two types. agonists or
- 17:39antagonists. And of those, of the
- 17:42agonists, we then have the pure and
- 17:44partial ones. Pure ones present
- 17:48affinity and intrinsic activity, and
- 17:50partial ones, of course, have affinity
- 17:53but lower intrinsic activity, that is,
- 17:55lower ability to agonize. Antagonists,
- 17:59on the other hand, have affinity, but
- 18:01no intrinsic activity. they basically
- 18:04work like plugs, meaning they block
- 18:06other agonist molecules from coming, in
- 18:09order to avoid receptor activation.
- 18:14According to the mechanism of action,
- 18:16we then have agonist drug A, which
- 18:18mixes with the receptor to form the
- 18:21drug-receptor or agonist-receptor
- 18:23complex and produces an effect, right?
- 18:27Similarly, we then have drug B, whose
- 18:30effect is to mix with the receptor to
- 18:32form the blocking-receptor or drug
- 18:35B-receptor complex; and in that way, we
- 18:37prevent the effect, since drug A will
- 18:40not be able to reach the receptor
- 18:42because the complex will already be
- 18:45formed, and thus there will be no
- 18:47effect at all. The dose-response curve
- 18:51is one of the points quite hated by all
- 18:54medical students, since they don't have
- 18:56a good or correct explanation for it.
- 18:58So today, I am going to try to explain
- 19:00it to you in a way that you can
- 19:01remember and interpret it very easily
- 19:03today. First, what will you be able to
- 19:05understand from this curve? the
- 19:08quantification of the drug's
- 19:10interaction with the receptor, the
- 19:12relationship of the dose to the effect,
- 19:14which is quite important. And finally,
- 19:17other concepts we derive from it, which
- 19:20are the effective dose, the maximum
- 19:22effect, that is, the intrinsic activity
- 19:24, and finally the slope of the curve,
- 19:27which will basically tell us the
- 19:29therapeutic margin. Now, if we
- 19:31extrapolate to the curve itself in
- 19:33order to explain it, this is the famous
- 19:38curve in a fairly simple or visual way.
- 19:42So, at this point, we notice the
- 19:44threshold that we must overcome for the
- 19:46drug to have an effect on the body. The
- 19:50effective dose 50, which is studied at
- 19:53this point to say: "Okay, the majority
- 19:55of patients had a beneficial effect
- 19:57from the use of the drug," remembering
- 19:59that at this point it is the response
- 20:01or percentage thereof; that is to say,
- 20:03the maximum dose we can use or the peak
- 20:05point the drug will reach. And once it
- 20:09reaches this, the curve goes down or
- 20:10stays for a while and then decreases.
- 20:15Another important point when we talk
- 20:17about pharmacological tolerance is the
- 20:18gradual decrease of the effect. What
- 20:21does continuous use of the drug mean?
- 20:23That it can be over a variable time, it
- 20:25can be days, months, years, and that
- 20:27the patient reports that it no longer
- 20:28has any effect, that the same dose no
- 20:30longer works for them, the same
- 20:31solution to their problems, etcetera.
- 20:34But on the other hand, tachyphylaxis is
- 20:36the sudden loss of the pharmacological
- 20:38effect, which is very different at
- 20:40usual doses. This is seen quite a lot
- 20:43with drugs like opioids, which are used
- 20:46quite a bit for pain, and the patient
- 20:48suddenly, within a week or even days
- 20:51and sometimes even with the first dose,
- 20:53can lose the effect of pain relief or
- 20:55analgesia.
About this transcript
This page contains the full transcript of FARMACOCINÉTICA Y FARMACODINAMIA esto es TODO LO QUE DEBES SABER | Farmacotips by Farmacotips , generated from the public captions YouTube serves with the video. The transcript has 3,106 words across 502 segments, with the original timestamps preserved so you can click any line to jump to that moment in the embedded player.
What you can do with it
Use the transcript to take notes, quote the speaker, build a study guide, generate a summary with ChatGPT or Claude via the YouTube Summary tool, or export it as a timed subtitle file with YouTube to SRT. You can also re-open it in the transcriber to choose a caption track available on the video.
Free YouTube transcript tool
YouTube2Text is a free YouTube transcript generator — no signup, no daily limit. Paste any YouTube link and get the full transcript instantly, with timestamps, click-to-jump, caption language selection, AI prompts for ChatGPT, Claude, and Gemini, and exports to TXT, SRT, VTT, or Markdown.